Proposal for Aquisition of LifeCell

LifeCell Corporation deals in developing, processing, as well as marketing of tissue-based products which are used in reconstructive, urogynecologic and orthopedic surgical processes to restore soft tissue defect in America and worldwide. LifeCell’s reconstructive products consist of AlloDerm used for plastic reconstruction, all-purpose surgical, burn up, and periodontal processes. in addition to Strattice, a porcine dermis which eliminates cells and lessens a constituent in the xenogeneic rejection reaction. LifeCell’s orthopedic tissue restore products include GraftJacket for restoring damaged or insufficient integumental tissue in orthopedic surgical procedures. The company was incorporated in 1992 in the State of Delaware. (LifeCell Company, 2007)
The company has a research and a development team which has ongoing research programs to develop new products required in the clinical applications and surgical applications to enlarge the company’s product mix in the highly fast growing bio-surgery industry. (LifeCell Company, 2007)
Sof…
2. GraftJacket. for orthopedic uses and lower end wounds
3. AlloCraft DBM. used for bone grafting processes
4. Repliform. used for urogynecologic surgical processes
5. Strattic. for specific plastic reconstruction and all-purpose surgical Processes
The company has a research and a development team which has ongoing research programs to develop new products required in the clinical applications and surgical applications to enlarge the company’s product mix in the highly fast growing bio-surgery industry. (LifeCell Company, 2007)
Industry overview
Soft tissue, for example dermis, blood vessels, nerve connective tissue and heart valve encloses an intricate, three-dimensional makeup which consists of manifold forms of elastin, proteoglycans, collagen several proteins as well as vessels (tissue matrix). As component of the human body’s normal remodeling procedure, cells
In a tissue constantly degrade during this process it replaces the tissue matrix. Nonetheless in the occasion of a large port of tissue matrix is lost or destroyed as a result of surgery or trauma, the human body cannot be able to regenerate that destroyed part this results in scar development. In such a case, surgeons encounter several treatment alternatives for repairing physiology and structure function, the alternatives includes using implants materials from the patient’s body parts ("autograft") or created allograft tissue or using synthetic products. The company believes that the best alternative is the use of allograft or xenograft from the company which do not cause tissues matrices to undergo any damages. (Covell, 2006):
Industry and market data
Table 2, below, has estimated market information of the company’s main products in the USA market. The